Simplifying Global Compliance
The Webinar Training Pass
Now get all the training you need – all in one place, and all for one low price!
The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.
PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!
If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.
Select webinars have been pre-approved by RAPS as eligible for up to 1.5 credits toward a participant’s RAC recertification. Please enter keyword RAPS below for a list of eligible on-demand webinars.
Already have an account? Login Here.
Webinar Training Pass
Recorded on: June 7, 2018
Description: Attorneys Gilliam Russell and Heather Banuelos discuss FDA and FTC trends in regulating advertising and promotion of medical products. They cover:
- Key focus areas and emerging trends;
- Risk disclosure;
- How such elements as music selection, pacing and distracting visuals can result in an enforcement letter; and
- FTC’s increasing focus on transparency as it bears on novel promotional strategies.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Gillian M. Russell, Counsel, and Heather Banuelos, Counsel, King & Spalding
Recorded on: June 5, 2018
Description: Clinical research expert Daniel Kavanagh discusses registration and reporting requirements for gene therapy research under the recently revised NIH guidelines. He covers:
- NIH reporting compliance;
- The Office of Science Policy registration process; and
- Progress and safety reporting requirements.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Daniel Kavanagh, Senior Director of Biosafety and Gene Therapy, WCG Biosafety
Recorded on: May 31, 2018
Description: Former FDA compliance officials Cynthia Schnedar and Howard Sklamberg discuss the Center for Drug Evaluation and Research’s plan for restructuring inspection and application review operations. Topics include:
- The new tone of interactions when approaching the agency on specific inspection and evaluation topics;
- What to expect from the FDA in conducting inspections and communicating results you need ASAP;
- New ways in which you’ll be able to encourage the FDA to meet commitments; and
- Difficulties facing the agency in implementing its new concept of operations.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Cynthia Schnedar, Executive VP-Regulatory Compliance, Greenleaf Health LLC; and Howard Sklamberg, Partner, Akin Gump Strauss Hauer & Feld LLP
Recorded on: May 30, 2018
Description: Patient recruitment expert Steven Pyffer discusses ways to reach potential research subjects through both tradition and digital avenues. He covers:
- Insight on the factors that determine the actual outreach cost of a randomized patient;
- Ways to reduce patient outreach cost; and
- Improved expectations to patient outreach performance.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Steven Pyffer, Senior Director of Patient Outreach, ThreeWire
Recorded on: May 24, 2018
Description: Strategic positioning expert Daniela Jansen discusses the all-digital solution known as “Quality 4.0.” She covers:
- Factors, processes and technologies to kickstart your digital journey;
- A platform-based strategy for Quality 4.0;
- How Quality 4.0 supports FDA regulations; and
- Examples of successful digital Quality 4.0 efforts.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Daniela Jansen, Director, Solution Marketing, Dassault Systèmes BIOVIA
Recorded on: May 22, 2018
Description: Pharmacovigilance expert Angela Pitwood looks at compliance challenges for gene therapies and other novel treatments in personalized medicine. She discusses:
- Cutting-edge therapies that offer hope for conditions for which there are limited or no therapeutic options now;
- Development of advanced therapies; and
- FDA safety reporting requirements, both now and in the future.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Angela Pitwood, Vice President of Pharmacovigilance, Vigilare
Recorded on: May 16, 2018
Description: Attorney Roseann Termini addresses implications of the opioid crisis for drugmakers, healthcare providers and other regulated firms. She discusses:
- False Claims Act crackdowns on GMP violations and opioid overprescribing;
- Impact of the Senate probe of donations by U.S. opioid manufacturers;
- Lawsuits at state, local and tribal levels;
- Opioid deterrents; and
- New regulations, warnings, dosage limits from the Gottlieb task force.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Roseann Termini, Food and Drug Lawyer
Recorded on: May 15, 2018
Description: Suicide treatment experts Larry Alphs, Jennifer Giddens and David Sheehan present latest trends and developments in measuring suicidal ideation and behavior. They discuss:
- Drug development targeting suicidality;
- What’s new in design and execution of studies of suicidal ideation and behavior;
- Phenotypes in suicidality; and
- Assessments in clinical trials for anti-suicidality treatments.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Larry Alphs, Therapeutic Area Leader, Ortho-McNeil Janssen; Jennifer Giddens, Co-founder & Co-director, Tampa Center for Research on Suicidality; and David Sheehan, Distinguished University Health Professor Emeritus, University of South Florida College of Medicine
Recorded on: May 8, 2018
Description: Food and drug specialist Will Woodlee explains how to take advantage of the many opportunities to communicate with the FDA. He discusses:
- How to avoid a warning letter;
- How to ask sensitive questions;
- Alternatives to direct engagement;
- What to do when your competitor isn’t complying with FDA requirements; and
- Identifying the correct agency point of contact.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Will Woodlee, Partner, Kleinfeld Kaplan & Becker LLP
Recorded on: May 3, 2018
Description: Food and drug law experts Areta Kupchyk and Paul Kim talk about the regulatory landscape for precision/personalized medicine. They discuss:
- Key points in two draft guidance documents;
- The level of evidence the FDA will accept to analytically validate additional or expanded application of next generation sequencing (NGS) tests;
- Pros and cons of various approaches, including implications of binding or non-binding recommendations; and
- FoundationOne CDx (F1CDx), the first breakthrough-designated NGS-based IVD test.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Areta Kupchyk, Partner, and Paul Kim, Partner, Foley Hoag LLP